• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

170787-99-2 (Efaproxiral (sodium))

1

Identification

Efaproxiral (sodium) Efaproxiral (sodium)
Name Efaproxiral (sodium)
Formula C20H22NNaO4
MW 363.3828
CAS No. 170787-99-2
EINECS
Smiles CC(C)(OC1=CC=C(CC(NC2=CC(C)=CC(C)=C2)=O)C=C1)C([O-])=O.[Na+]
Synonyms RSR13 sodium
InChI InChI=1S/C20H23NO4.Na/c1-13-9-14(2)11-16(10-13)21-18(22)12-15-5-7-17(8-6-15)25-20(3,4)19(23)24;/h5-11H,12H2,1-4H3,(H,21,22)(H,23,24);/q;+1/p-1
2

Introduction

Efaproxiral Sodium is a synthetic allosteric modifier of hemoglobin, used for brain metastases originating from breast cancer.

Background Information

Efaproxiral, a synthetic allosteric modi?er of hemoglobinoxygen binding af?nity, has been shown to bind reversibly to hemoglobin, stabilizing the deoxyhemoglobin tetramer conformation to reduce its af?nity for oxygen. ......by BOC Sciences
Efaproxiral Sodium is a synthetic allosteric modifier of hemoglobin, used for brain metastases originating from breast cancer. ......by Selleck Chemicals LLC
Efaproxiral Sodium is a synthetic allosteric modifier of hemoglobin, used for brain metastases originating from breast cancer. ......by Target Molecule Corp.
3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

4

Physical and Chemical Properties

Appearance:White to off-white Solid EBNumber:EB000016382

Storage condition

4°C by MedChemexpress Co., Ltd.

Solubility

DMSO:39mg/mL by CHEMSCENE, LLC
DMSO:39mg/mL by MedChemexpress Co., Ltd.
(25°C) * In vitro DMSO 73 mg/mL (200.89 mM); Water73 mg/mL (200.89 mM); Ethanol73 mg/mL (200.89 mM) by Selleck Chemicals LLC
5

Mechanism and Indication

Signaling Pathways Others
Target Others
Research Area Cancer
Indications
6

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
Efaproxiral (sodium) - Not Found
Efaproxiral (sodium) - No Development Reported
7

Safety Data of Efaproxiral (sodium)

8

Spectral Information

9

Suppliers List

Company Price and Availability Country/Region
Ark Pharm, Inc. USA
BOC Sciences
Beijing Bode United Chemical Co., Ltd. China
Bide Pharmatech Ltd. 1g/USD680() China
Biochempartner Co., Ltd China
CHEMSCENE, LLC 50mg/USD84() USA
MedChemexpress Co., Ltd. 50mg/USD84() USA
Selleck Chemicals LLC 50mg/USD97(In stock) USA
Shanghai Haoyuan Chemexpress Co., Ltd. 50mg/USD84() China
Target Molecule Corp. 50mg/USD66();100mg/USD96() USA
10

Related Products

Other Forms of 170787-99-2

Name CAS No Formula MW
Efaproxiral 131179-95-8 C20H23NO4 341.4

Recommended Compounds in Others

Name CAS No Formula MW
(R)-(+)-Etomoxir (sodium salt) 828934-41-4 C15H18ClNaO4 320.74
Dictamine 484-29-7 C12H9NO2 199.21
3,3',5-Triiodo-L-thyronine (sodium) 55-06-1 C15H11I3NNaO4 672.9553
Fabomotizole (hydrochloride) 173352-39-1 C15H22ClN3O2S 343.8721
FPH2 957485-64-2 C14H16ClN5O2S 353.83
α-Tocopherol (phosphate) 38976-17-9 C29H51O5P 510.69
BAMB-4 891025-25-5 C15H12N2O2 252.27
LDN-27219 312946-37-5 C20H16N4O2S2 408.5
ISO-1 478336-92-4 C12H13NO4 235.24
Aurothioglucose 12192-57-3 C6H11AuO5S 392.18
Oxybenzone 131-57-7 C14H12O3 228.24
ITX3 347323-96-0 C22H17N3OS 371.45
Cardiogreen 3599-32-4 C43H47N2NaO6S2 774.96
Skp2 Inhibitor C1 432001-69-9 C18H13BrN2O4S2 465.34
INH1 313553-47-8 C18H16N2OS 308.4
PF6-AM 1268491-69-5 C33H31BO12 630.4
XEN445 1515856-92-4 C18H17F3N2O3 366.33
Disperse Blue 148 52239-04-0 C19H19N5O4S 413.45026
Solvent Blue 35 17354-14-2 C22H26N2O2 350.454
CID-797718 370586-05-3 C12H11NO3 217.2206

Recommended Compounds in Same Indication

Name CAS No Formula MW
11

Route of Synthesis

12

References

13

More Information

Efaproxiral (sodium)

Tags: buy 170787-99-2 IC50 | 170787-99-2 price | 170787-99-2 cost | 170787-99-2 solubility | 170787-99-2 purchase | 170787-99-2 manufacturer | 170787-99-2 research buy | 170787-99-2 order | 170787-99-2 MSDS | 170787-99-2 chemical structure | 170787-99-2 Storage condition | 170787-99-2 molecular weight | 170787-99-2 mw | 170787-99-2 datasheet | 170787-99-2 supplier | 170787-99-2 cell line | 170787-99-2 NMR | 170787-99-2 MS | 170787-99-2 IR | 170787-99-2 solubility | 170787-99-2 Safe information | 170787-99-2 Qc and Spectral Information | 170787-99-2 Clinical Information | 170787-99-2 Clinical Trial | 170787-99-2 Route of Synthesis | 170787-99-2 storage condition | 170787-99-2 diseases and conditions | 170787-99-2 flash point | 170787-99-2 boiling point | 170787-99-2 melting point | 170787-99-2 storage condition | 170787-99-2 brand